IMV Inc. (NASDAQ:IMV) has scheduled a conference call for 12th November 2020 at 8:00 AM Eastern Time to announce its 3Q20 financial results.
The conference call will also be webcast live under the investor relations section of the website imv-inc.com
Earnings Expectation
IMV Inc. is reporting third quarter earnings results on Thursday 12th November 2020, before market open.
IMV Inc., a clinical-stage immuno-oncology company, together with its subsidiaries, develops products based on its platform and products with a primary focus on T cell activating therapies for cancer. The companys DPX drug development platform provides a patented delivery formulation that enables controlled and prolonged exposure of antigens to the immune system. The company develops DPX-Survivac, T cell activating immunotherapy that is in Phase II clinical trials for ovarian cancer and diffuse large B-cell lymphoma.
